FundLens
50
Pharma & HealthcareHold

WhiteOak Capital Pharma And Heathcare

WhiteOak · Direct–Growth · rank #10 of 19 by Smart Score

Data updated

Trailing returns

vs Nifty 500 (index-fund proxy)
1 Year
14.9%
+19.6% vs index
3 Years
—
5 Years
—
Since launch
20.5%

Why this score

WhiteOak Capital Pharma And Heathcare scores 50/100 — #10 of 19 Pharma & Healthcare fund (Hold). It stands out for 1y return — beating 79% of peers on 1y return. The main drag is its expense ratio (better than only 34% of peers).

Each bar shows the fund's percentile vs Pharma & Healthcare peers — a longer bar beats more of the category.

1Y return14.86% · 79th percentile in category
Expense ratio1.09% · 34th percentile in category
Fund size926.55 Cr · 50th percentile in category

Top holdings

top 5 = 27.2% of portfolio
1.Divi's Laboratories Ltd7.73%
2.Sun Pharmaceutical Industries Ltd6.57%
3.Torrent Pharmaceuticals Ltd5.78%
4.Laurus Labs Ltd3.61%
5.Apollo Hospitals Enterprise Ltd3.47%

56 disclosed equity positions · portfolio as of Sept 2026 · weights are % of total corpus.

Other Pharma & Healthcare funds